Company Overview
About Disc Medicine
Disc Medicine is a clinical-stage biopharmaceutical company founded in 2021 and headquartered in Watertown, Massachusetts, focused on developing novel therapies for serious hematologic disorders. The company's scientific foundation lies in understanding red blood cell biology — specifically heme biosynthesis (the process by which cells produce heme, the oxygen-carrying component of hemoglobin) and iron homeostasis (how the body regulates iron). By targeting these pathways, Disc Medicine aims to address diseases where current treatments are inadequate, including polycythemia vera (PV), myelofibrosis, and other bone marrow-driven blood disorders.
Business Model & Competitive Advantage
Disc Medicine's lead clinical asset is bitercept (formerly DISC-0974), an anti-hemojuvelin antibody that suppresses hepcidin — the master regulator of iron absorption — to mobilize iron for red blood cell production in conditions of functional iron deficiency. The company also advances DISC-3405, a targeting agent with a distinct mechanism. Disc Medicine went public on the Nasdaq under ticker IRON and has raised over $175M through its IPO and subsequent public offerings, funding multiple ongoing Phase 1 and Phase 2 trials. The company has assembled a leadership team with deep expertise from Acceleron Pharma, Agios Pharmaceuticals, and Blueprint Medicines.
Competitive Landscape 2025–2026
The hematology rare disease space is competitive but characterized by large unmet need: polycythemia vera affects approximately 100,000–150,000 patients in the US, and myelofibrosis affects roughly 20,000 patients, many of whom progress through existing therapies. Disc Medicine's approach — targeting the underlying biology of red blood cell production rather than symptomatic management — positions its pipeline as potentially disease-modifying, a key differentiator that supports its premium positioning in a space where Incyte and AbbVie dominate with JAK inhibitors.
Key Differentiators
Emerging Innovator
Disc Medicine is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Compare Disc Medicine with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Disc Medicine? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Disc Medicine Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Disc Medicine vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →